πŸ‡ΊπŸ‡Έ FDA
Patent

US 11225648

Modified DNase and uses thereof

granted A61KA61K38/00A61K38/465

Quick answer

US patent 11225648 (Modified DNase and uses thereof) held by Protalix Ltd. expires Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Protalix Ltd.
Grant date
Tue Jan 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K38/00, A61K38/465, A61P, A61P11/00